Joshua Brumm – Biography
Last update: March 19, 2026Executive profile
Joshua was President & Chief Executive Officer at Dyne Therapeutics, and Chief Operating Officer and Chief Financial Officer at Kaleido Biosciences. Joshua Brumm joined Amphista Therapeutics in 2025.
Joshua Brumm is currentlyChief Executive Officer at Crescent Biopharma - View - Crescent Biopharma org chart
Independent Chairman of the Board at Amphista Therapeutics - View - Amphista Therapeutics org chart
Create your alert
to follow the career of Joshua Brumm.
More about Joshua Brumm
Selected links
Do you need to know more about Joshua Brumm? More results.
Participate
Social media
- Joshua Brumm on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Joshua Brumm
The colleagues of Joshua Brumm
Company Colleagues
- At Crescent Biopharma, Joshua Brumm has 21 colleagues including David Lubner (Director), Jonathan Violin (Director)…
- At Amphista Therapeutics, Joshua Brumm has 17 colleagues including Louise Modis (CEO), Rogier Rooswinkel (Director)…
Industry Colleagues
- In the Biotechnology industry, Joshua Brumm has 35,756 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Joshua Brumm.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Joshua Brumm.
